Robust evidence from a large international study confirms that a difference in blood pressure readings between arms is linked to greater risk of heart attack, stroke and death.
For the second year, Philippe Géneréux, MD, Co-Director of the Structural Heart Program at Atlantic Health System’s Morristown Medical Center and an interventional cardiologist internationally known for his novel research, has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group. Dr. Géneréux is the only New Jersey-based physician-scientist to be named to this year’s list in the Clinical Medicine category. Clinical Medicine requires more highly cited papers than any other field to meet the criteria for inclusion on the Highly Cited list.
More than a decade after committing $130+ billion to Closing the Gap, there has been little improvement in health outcomes experienced by Aboriginal and Torres Strait Islander populations.
Researchers at the University of Eastern Finland and Kuopio University Hospital have discovered several new biomarkers that are associated with incident heart failure.
Clinicians are often asked to assess competitive athletes with cardiovascular symptoms and to screen asymptomatic athletes for hidden heart problems.
A new study has revealed paying patients are 20 per cent less likely to die or develop major complications, such as reintervention or stroke, after cardiac surgery than NHS patients – findings researchers say cannot be explained by socioeconomic factors alone.
Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month. From the beginning, most scientists have said that COVID-19 is deadlier than the seasonal flu, while fringe theories have circulated widely, suggesting it is less deadly or flu’s equal. Evidence is accumulating, however, to show just how much deadlier COVID-19 is compared with the flu and the extent of complications related to the two illnesses.
DALLAS – Dec. 15, 2020 – A study of patients resuscitated from out-of-hospital cardiac arrest shows that women have a lower likelihood of survival compared with men and are less likely to receive procedures commonly administered following cardiac arrest.
DALLAS – Dec. 14, 2020 – Recently published UT Southwestern research reveals new insights about risk factors for depression based on data from a landmark longitudinal study focused on heart disease.
Jefferson researchers find that the genetic underpinnings of a skin disorder at birth indicate future heart problems.
Black neighborhoods had a significantly lower rate of bystander automated external defibrillator (AED) use relative to non-Hispanic/Latino white communities, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).
Engineers have created 3D printed patient-specific models of the aorta that can aid presurgical planning and improve outcomes of minimally invasive valve replacement.
Scientists at St. Jude Children’s Research Hospital have identified genetic variants in African American childhood cancer survivors that have implications for up-front care and long-term surveillance.
Heart disease is the main cause of death in developed countries.
All educational programming from TCT Connect will be available to registrants for free through October 18, 2021. TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
People who have coronary artery disease, stroke or peripheral artery disease often are prescribed a statin, a cholesterol-lowering drug that reduces the risk of heart attack or stroke.In a recent publication in JAMA Network Open, Mayo Clinic researchers identify trends in statin use across the U.S. among people with these diseases, as well as among those who already had a stroke or transient ischemic attack (TIA). Their data indicate that only about 60% of patients are getting the recommended therapy.
Just moments after Calabasas ninth grader Oliver Merlob was born, he was whisked away for open-heart surgery to treat a congenital heart defect. Little did his parents know it would be the beginning of a lifelong relationship.
Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men, according to new research published today in the American Heart Association's flagship journal Circulation.
Researchers have found that differences in the left atrium in the hearts of Black people and white people may play a role in risk of stroke, according to a new study published in the November 25, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.
In-hospital cardiac arrests (IHCA) represent catastrophic and often terminal events. Despite investments to improve the quality of resuscitation efforts, fewer than 25% of all patients that experience cardiac arrests in hospitals survive to discharge, and survival varies significantly across hospitals and by race. Until now, few have been able to specify reasons for the between-hospital differences.
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.
In recognition of its expertise in treating adults with congenital heart disease (ACHD), the Mount Sinai Adult Congenital Heart Disease Center has been accredited by the Adult Congenital Heart Association (ACHA) as a Comprehensive Care Center.
Resuscitation and survival rates for hospitalized COVID-19 patients who have cardiac arrest are much higher than earlier reports of near-zero; variation at the individual hospital level may have affected overall numbers
Buenos Aires, Argentina 19 November 2020: Lockdown due to the COVID-19 pandemic is associated with an increase in high blood pressure among patients admitted to emergency. That's the finding of a study presented at the 46th Argentine Congress of Cardiology (SAC).
Research may lead to identifying novel therapies for cardiac patients
Do people with COVID-19 run a risk of developing myocarditis? Cardiologist Dr. John Boehmer examines the latest research in this week’s Medical Minute.
Los estudios sobre una enfermedad cardíaca genética expusieron un mecanismo nuevo e inesperado de la insuficiencia cardíaca. Este descubrimiento emblemático encontró una correlación entre el agrupamiento de proteínas ligadas al ARN y los agregados de proteína existentes en tejidos cardíacos con miocardiopatía dilatada por el gen RBM20.
Only program in New York City to receive prestigious recognition
The Cardiovascular Research Foundation (CRF) has announced that the 2021 Chronic Total Occlusion (CTO) Summit will now take place as a virtual event called CTO Connect. It will take place online February 20-21, 2021. The conference will feature live case transmissions performed by some of the world’s leading operators along with real-time analysis from world-class faculty members. Live and on-demand sessions will also highlight engaging case-based discussions, challenging cases, and the latest technical developments and refinements in CTO PCI.
DALLAS – Nov. 17, 2020 – Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.
For many of us, this year’s holiday season may look different, and many are asking how we can enjoy the fellowship of the season while keeping ourselves, our loved ones and our communities safe from COVID-19.
DALLAS – Nov. 17, 2020 – Being younger doesn’t protect against the dangers of COVID-19 if you are overweight, according to a new study from UT Southwestern. While all adults who are overweight or obese are at greater risk for serious complications from the disease, the link is strongest for those age 50 and under.
People taking dummy pills and statins experienced similar side effects in a new study.
Adults with the healthiest sleep patterns had a 42% lower risk of heart failure regardless of other risk factors compared to adults with unhealthy sleep patterns, according to new research published today in the American Heart Association's flagship journal Circulation.
A new national policy was created to make determining who receives a heart transplant more fair. But new data shows it changed some practice patterns, too.
For the first time, a medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, hypertrophic cardiomyopathy, rather than simply addressing their symptoms.
Cleveland: Cleveland Clinic researchers have found that cryoballoon ablation as the initial treatment for atrial fibrillation is more effective than current standard-of-care management using medications. The study was published today in the New England Journal of Medicine.
The research team discovered it could improve irregular heart rhythms – even when the heart’s blood supply was completely shut off – by altering concentrations of common electrolytes in the bloodstream.
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and other global academic sites has found.
Cleveland: Findings from a new Cleveland Clinic study do not support the use of a high dose omega-3 fatty acid formulation to reduce major adverse cardiovascular events in patients with high cardiovascular risk. Findings from the STRENGTH Trial: Cardiovascular Outcomes With Omega-3 Carboxylic Acids (Epanova) In Patients With High Vascular Risk And Atherogenic Dyslipidemia were reported today during a Late Breaking Science session at the American Heart Association’s virtual Scientific Sessions 2020. The findings were also simultaneously published online in the Journal of the American Medical Association.
Mount Sinai clinical trial results could help lead to FDA approval
New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance.
The information came from the International Polycap Study 3 (TIPS-3) study which followed the participants an average of 4.6 years. The study of 5,714 people from nine countries, particularly India and the Philippines, looked at the polypill alone compared to a placebo; aspirin alone versus a placebo, and the polypill plus aspirin versus a double placebo. The men in the study were 50 or older and the women were 55 or older.
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure. This landmark discovery found a correlation between the clumping of RNA-binding proteins ― long linked to neurodegenerative disease ― and the aggregates of protein found in the heart tissue of patients with RBM20 dilated cardiomyopathy.
Thanks to a data-driven and boots-on-the-ground approach, 219 medical practices in North Carolina were able to reduce the percent of patients at a high 10-year risk of serious cardiovascular events from 23 percent to 17 percent. After adjusting for clinical-patient efforts outside this intervention, the 25 percent relative reduction is essentially equivalent to preventing 6,000 patients from suffering a heart attack or stroke, or dying due to cardiovascular disease within 10 years.
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the distribution of a person’s body fat affects coronary heart disease risk, with an increased risk of heart events among people with a combination of high visceral adipose tissue (VAT) – abdominal fat─ and low liver fat. The study’s findings indicate that liver triglyceride regulation plays an important role in heart health in people with discordant visceral adipose tissue and liver fat levels.
MedStar Washington Hospital Center became first in Washington, D.C. and central Maryland to adopt the HeartFlow® Analysis, a first-of-its-kind non-invasive technology to help physicians diagnosis heart disease and determine the next steps in treatment for each patient.
Thailand’s Royal Family has named Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, a winner of the 29th annual Prince Mahidol Award in the field of Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right